Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Emile

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Blood|July 13, 2000
Langerhans cell deficiency in reticular dysgenesisJ F Emile, F Geissmann, O C Martin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patientsM Ilie, E Long, V Hofman, et al.
The Journal of Clinical Investigation|February 12, 1998
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosisE Jouanguy, S Lamhamedi-Cherradi, F Altare, et al.
British Journal of Haematology|April 7, 1999
Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four casesC Bayle, A Charpentier, E Duchayne, et al.
Annales De Dermatologie Et De Venereologie|August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]B Guillot, S Dalac, M G Denis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and managementB Guillot, S Dalac, M G Denis, et al.
British Journal of Cancer|June 19, 2009
Prognosis and predictive value of KIT exon 11 deletion in GISTsJ-B Bachet, I Hostein, A Le Cesne, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Loss of SMARCB1 expression in colon carcinomaS Melloul, J-F Mosnier, J Masliah-Planchon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)D Basile, C Broudin, J F Emile, et al.
The Journal of Pathology|January 1, 1997
Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infectionJ F Emile, N Patey, F Altare, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Blood|July 13, 2000
Langerhans cell deficiency in reticular dysgenesisJ F Emile, F Geissmann, O C Martin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patientsM Ilie, E Long, V Hofman, et al.
The Journal of Clinical Investigation|February 12, 1998
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosisE Jouanguy, S Lamhamedi-Cherradi, F Altare, et al.
British Journal of Haematology|April 7, 1999
Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four casesC Bayle, A Charpentier, E Duchayne, et al.
Annales De Dermatologie Et De Venereologie|August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]B Guillot, S Dalac, M G Denis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and managementB Guillot, S Dalac, M G Denis, et al.
British Journal of Cancer|June 19, 2009
Prognosis and predictive value of KIT exon 11 deletion in GISTsJ-B Bachet, I Hostein, A Le Cesne, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Loss of SMARCB1 expression in colon carcinomaS Melloul, J-F Mosnier, J Masliah-Planchon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)D Basile, C Broudin, J F Emile, et al.
The Journal of Pathology|January 1, 1997
Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infectionJ F Emile, N Patey, F Altare, et al.
Pageof 12